107 related articles for article (PubMed ID: 9334825)
1. Increased MRP expression is associated with resistance to radiation, anthracyclines and etoposide in cells treated with fractionated gamma-radiation.
Harvie RM; Davey MW; Davey RA
Int J Cancer; 1997 Sep; 73(1):164-7. PubMed ID: 9334825
[TBL] [Abstract][Full Text] [Related]
2. The relationship between modulation of MDR and glutathione in MRP-overexpressing human leukemia cells.
Grech KV; Davey RA; Davey MW
Biochem Pharmacol; 1998 Apr; 55(8):1283-9. PubMed ID: 9719484
[TBL] [Abstract][Full Text] [Related]
3. Comparison of drug accumulation in P-glycoprotein-expressing and MRP-expressing human leukaemia cells.
Davey MW; Hargrave RM; Davey RA
Leuk Res; 1996 Aug; 20(8):657-64. PubMed ID: 8913319
[TBL] [Abstract][Full Text] [Related]
4. An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.
Doyle LA; Ross DD; Ordonez JV; Yang W; Gao Y; Tong Y; Belani CP; Gutheil JC
Br J Cancer; 1995 Sep; 72(3):535-42. PubMed ID: 7669558
[TBL] [Abstract][Full Text] [Related]
5. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
[TBL] [Abstract][Full Text] [Related]
6. Amplification and expression of the ABC transporters ARA and MRP in a series of multidrug-resistant leukaemia cell sublines.
O'Neill GM; Peters GB; Harvie RM; MacKenzie HB; Henness S; Davey RA
Br J Cancer; 1998 Jun; 77(12):2076-80. PubMed ID: 9649117
[TBL] [Abstract][Full Text] [Related]
7. Drug resistance mechanisms and MRP expression in response to epirubicin treatment in a human leukaemia cell line.
Davey RA; Longhurst TJ; Davey MW; Belov L; Harvie RM; Hancox D; Wheeler H
Leuk Res; 1995 Apr; 19(4):275-82. PubMed ID: 7752673
[TBL] [Abstract][Full Text] [Related]
8. Radiation resistance in a multidrug resistant human T-cell leukemia line.
Shimm DS; Olson S; Hill AB
Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):931-6. PubMed ID: 3182332
[TBL] [Abstract][Full Text] [Related]
9. Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIalpha expression.
Henness S; Davey MW; Harvie RM; Davey RA
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):895-902. PubMed ID: 12377343
[TBL] [Abstract][Full Text] [Related]
10. The anthracycline resistance-associated (ara) gene, a novel gene associated with multidrug resistance in a human leukaemia cell line.
Longhurst TJ; O'Neill GM; Harvie RM; Davey RA
Br J Cancer; 1996 Nov; 74(9):1331-5. PubMed ID: 8912525
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide.
Nielsen D; Maare C; Eriksen J; Litman T; Friche E; Skovsgaard T
Biochem Pharmacol; 2000 Aug; 60(3):353-61. PubMed ID: 10856430
[TBL] [Abstract][Full Text] [Related]
12. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
Ross DD; Doyle LA; Schiffer CA; Lee EJ; Grant CE; Cole SP; Deeley RG; Yang W; Tong Y
Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
14. Development of drug resistance is reduced with idarubicin relative to other anthracyclines.
Hargrave RM; Davey MW; Davey RA; Kidman AD
Anticancer Drugs; 1995 Jun; 6(3):432-7. PubMed ID: 7670142
[TBL] [Abstract][Full Text] [Related]
15. Induction of broad drug resistance in small cell lung cancer cells and its reversal by paclitaxel.
Su GM; Davey MW; Davey RA
Int J Cancer; 1998 May; 76(5):702-8. PubMed ID: 9610729
[TBL] [Abstract][Full Text] [Related]
16. [Expression of ATP binding cassette superfamily (multidrug resistance-1, multidrug resistance-associated protein, human canalicular multispecific organ anion transporter) mRNA in etoposide and m-AMSA resistant cell lines].
Matsumoto Y; Matsumoto M; Minemura M; Takano H; Nagao S; Iglesias A; Fojo T
Gan To Kagaku Ryoho; 1997 Oct; 24(13):1941-6. PubMed ID: 9350240
[TBL] [Abstract][Full Text] [Related]
17. Drug resistance does not correlate with resistance to Fas-mediated apoptosis.
Cullen KV; Davey RA; Davey MW
Leuk Res; 2001 Jan; 25(1):69-75. PubMed ID: 11137563
[TBL] [Abstract][Full Text] [Related]
18. Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells.
Berger W; Hauptmann E; Elbling L; Vetterlein M; Kokoschka EM; Micksche M
Int J Cancer; 1997 Mar; 71(1):108-15. PubMed ID: 9096673
[TBL] [Abstract][Full Text] [Related]
19. Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction.
Ax W; Soldan M; Koch L; Maser E
Biochem Pharmacol; 2000 Feb; 59(3):293-300. PubMed ID: 10609558
[TBL] [Abstract][Full Text] [Related]
20. Modulation of P-glycoprotein-mediated multidrug resistance in a doxorubicin-resistant subline of the human lymphoblastoid cell line CCRF-CEM by phosphorothioate antisense oligonucleotides.
Dassow H; Lassner D; Remke H; Preiss R
Int J Clin Pharmacol Ther; 1998 Feb; 36(2):93-6. PubMed ID: 9520155
[No Abstract] [Full Text] [Related]
[Next] [New Search]